It is what it is. Anyone making negative comments

It is what it is. Anyone making negative comments concerning SCRC's January's revenues is ignorant and does not understand the impact deductibles have on the pharmaceutical market. From SCRC to the big hitters like Merck, Pfizer, and Lilly, they all see this impact in January and even early February revenues. And they were also impacted by the bad weather. Nothing to worry about here. Ask Mr. Schneiderman stated, the revenues will bounce back. Plus, don't forget we still haven't seen PIMD revenues, or the diabetes revenue stream. We are good to go. SCRC is strong as ever.